Sweden Pharmaceuticals

SynAct Pharma AB (SYNACT)

Track

Track

SynAct Pharma AB experienced two significant sell transactions totaling 8.9 million SEK on September 2, 2026, involving the CEO and a senior executive. These divestments occurred following a 34.1% stock price increase over the last quarter, despite no recent earnings report updates. Previous activity earlier this year primarily consisted of smaller insider purchases.
Ticker: SYNACT Exchange: STO
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for SynAct Pharma AB. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders

Similar companies

View all Pharmaceuticals companies
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.9
Thomas Jonassen Other senior executive Officer
Through TJ Biotech Holding ApS, a closely affiliated person
Transaction date
Sale
Price
57.82
Quantity 78,034
Value SEK3,914,339
3.4
Jeppe Øvlesen Chief Executive Officer (CEO)/Managing Directory Officer
Through Quantass ApS, a closely affiliated person
Transaction date
Sale
Price
257.44
Quantity 7,146
Value SEK4,875,215
3.9
Anders Kronborg Chairman of the Board of Directors Director
Transaction date
Purchase
Price
46.86
Quantity 45,714
Value SEK3,987,899
3.9
Anders Kronborg Chairman of the Board of Directors Director
Transaction date
Purchase
Price
18.12
Quantity 3
Value SEK50
1.5
Jeppe Øvli Øvlesen Chief Executive Officer (CEO)/Managing Directory Officer
Through Quantass ApS, a closely affiliated person
Transaction date
Purchase
Price
17.99
Quantity 7,900
Value SEK142,146
1.5
Mads Liebach Bjerregaard Other member of the company's administrative, management or supervisory body
Transaction date
Purchase
Price
17.92
Quantity 1,500
Value SEK26,880
3.8
Thomas Boesen Other member of the company's administrative, management or supervisory body
Through Boesen Biotech ApS, a closely affiliated person
Transaction date
Purchase
Price
17.92
Quantity 2,750
Value SEK49,280
3.8
Thomas Boesen Other member of the company's administrative, management or supervisory body
Through Boesen Biotech ApS, a closely affiliated person
Transaction date
Purchase
Price
17.90
Quantity 2,700
Value SEK48,330
3.9
Thomas Jonassen Other senior executive Officer
Through TJ Biotech Holding Aps, a closely affiliated person
Transaction date
Purchase
Price
20.45
Quantity 3,529
Value SEK72,168
3.9
Anders Kronborg Chairman of the Board of Directors Director
Transaction date
Purchase
Price
20.84
Quantity 3,470
Value SEK72,301
1.6
Quantass ApS Chief Executive Officer (CEO)/Managing Directory Officer
Transaction date
Purchase
Price
20.24
Quantity 3,529
Value SEK71,429
2.9
Björn Westberg Chief Financial Officer (CFO) Officer
Transaction date
Purchase
Price
17.52
Quantity 2,440
Value SEK42,749
3.6
Jeppe Oevlesen Chief Executive Officer (CEO)/Managing Directory Officer
Through Quantass ApS, a closely affiliated person
Transaction date
Purchase
Price
17.55
Quantity 2,757
Value SEK48,388
3.8
Sten Sörensen Member of the Board of Directors Director
Transaction date
Purchase
Price
16.41
Quantity 3,048
Value SEK50,021
3.9
Thomas Jonassen Other member of the company's administrative, management or supervisory body
Through TJ Biotech Holding Aps, a closely affiliated person
Transaction date
Purchase
Price
16.31
Quantity 18,800
Value SEK306,684
3.9
Anders Kronborg Chairman of the Board of Directors Director
Transaction date
Purchase
Price
16.19
Quantity 6,150
Value SEK99,556
3.6
Jeppe Oevlesen Chief Executive Officer (CEO)/Managing Directory Officer
Through Quantass ApS, a closely affiliated person
Transaction date
Purchase
Price
16.04
Quantity 18,500
Value SEK296,819
3.8
Thomas Boesen Other member of the company's administrative, management or supervisory body
Through Boesen Biotech ApS, a closely affiliated person
Transaction date
Purchase
Price
16.22
Quantity 6,250
Value SEK101,380
3.8
Sten Sörensen Member of the Board of Directors Director
Transaction date
Purchase
Price
8.65
Quantity 5,780
Value SEK49,997
3.8
Thomas Boesen Other senior executive Officer
Through Boesen Biotech ApS, a closely affiliated person
Transaction date
Purchase
Price
8.65
Quantity 17,341
Value SEK150,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-07 2026-09-02 S Sale
3.9
Thomas Jonassen

Other senior executive

Through TJ Biotech Holding ApS, a closely affiliated person Officer
78,034
57.82
SEK3,914,339 		78,034 57.82 SEK3,914,339
2026-09-07 2026-09-02 S Sale
3.4
Jeppe Øvlesen

Chief Executive Officer (CEO)/Managing Directory

Through Quantass ApS, a closely affiliated person Officer
7,146
257.44
SEK4,875,215 		7,146 257.44 SEK4,875,215
2026-03-10 2026-03-10 B Purchase
3.9
Anders Kronborg

Chairman of the Board of Directors

Director
45,714
46.86
SEK3,987,899 		45,714 46.86 SEK3,987,899
2026-03-10 2026-03-10 B Purchase
3.9
Anders Kronborg

Chairman of the Board of Directors

Director
3
18.12
SEK50 		3 18.12 SEK50
2026-03-09 2026-03-05 B Purchase
1.5
Jeppe Øvli Øvlesen

Chief Executive Officer (CEO)/Managing Directory

Through Quantass ApS, a closely affiliated person Officer
7,900
17.99
SEK142,146 		7,900 17.99 SEK142,146
2026-03-09 2026-03-05 B Purchase
1.5
Mads Liebach Bjerregaard

Other member of the company's administrative, management or supervisory body
1,500
17.92
SEK26,880 		1,500 17.92 SEK26,880
2026-03-06 2026-03-03 B Purchase
3.8
Thomas Boesen

Other member of the company's administrative, management or supervisory body

Through Boesen Biotech ApS, a closely affiliated person
2,750
17.92
SEK49,280 		2,750 17.92 SEK49,280
2026-03-06 2026-03-03 B Purchase
3.8
Thomas Boesen

Other member of the company's administrative, management or supervisory body

Through Boesen Biotech ApS, a closely affiliated person
2,700
17.90
SEK48,330 		2,700 17.90 SEK48,330
2025-12-31 2025-12-19 B Purchase
3.9
Thomas Jonassen

Other senior executive

Through TJ Biotech Holding Aps, a closely affiliated person Officer
3,529
20.45
SEK72,168 		3,529 20.45 SEK72,168
2025-12-22 2025-12-19 B Purchase
3.9
Anders Kronborg

Chairman of the Board of Directors

Director
3,470
20.84
SEK72,301 		3,470 20.84 SEK72,301
2025-12-22 2025-12-17 B Purchase
1.6
Quantass ApS

Chief Executive Officer (CEO)/Managing Directory

Officer
3,529
20.24
SEK71,429 		3,529 20.24 SEK71,429
2025-06-25 2025-06-25 B Purchase
2.9
Björn Westberg

Chief Financial Officer (CFO)

Officer
2,440
17.52
SEK42,749 		2,440 17.52 SEK42,749
2025-06-25 2025-06-25 B Purchase
3.6
Jeppe Oevlesen

Chief Executive Officer (CEO)/Managing Directory

Through Quantass ApS, a closely affiliated person Officer
2,757
17.55
SEK48,388 		2,757 17.55 SEK48,388
2025-06-25 2025-06-23 B Purchase
3.8
Sten Sörensen

Member of the Board of Directors

Director
3,048
16.41
SEK50,021 		3,048 16.41 SEK50,021
2025-06-25 2025-06-23 B Purchase
3.9
Thomas Jonassen

Other member of the company's administrative, management or supervisory body

Through TJ Biotech Holding Aps, a closely affiliated person
18,800
16.31
SEK306,684 		18,800 16.31 SEK306,684
2025-06-25 2025-06-19 B Purchase
3.9
Anders Kronborg

Chairman of the Board of Directors

Director
6,150
16.19
SEK99,556 		6,150 16.19 SEK99,556
2025-06-25 2025-06-19 B Purchase
3.6
Jeppe Oevlesen

Chief Executive Officer (CEO)/Managing Directory

Through Quantass ApS, a closely affiliated person Officer
18,500
16.04
SEK296,819 		18,500 16.04 SEK296,819
2025-06-25 2025-06-19 B Purchase
3.8
Thomas Boesen

Other member of the company's administrative, management or supervisory body

Through Boesen Biotech ApS, a closely affiliated person
6,250
16.22
SEK101,380 		6,250 16.22 SEK101,380
2025-01-03 2025-01-03 B Purchase
3.8
Sten Sörensen

Member of the Board of Directors

Director
5,780
8.65
SEK49,997 		5,780 8.65 SEK49,997
2025-01-03 2024-12-30 B Purchase
3.8
Thomas Boesen

Other senior executive

Through Boesen Biotech ApS, a closely affiliated person Officer
17,341
8.65
SEK150,000 		17,341 8.65 SEK150,000
Explore more

More insider trading research around SynAct Pharma AB

More insider trades in Sweden
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in Europe